During the last three months, 7 analysts shared their evaluations of Azenta (NASDAQ:AZTA), revealing diverse outlooks from bullish to bearish. The table below provides a snapshot of their recent ...

Business: Azenta is a life sciences company that operates through two segments. First, there's the life sciences products division, which offers automated cold sample management systems for compound ...

Life sciences company Azenta (NASDAQ:AZTA) reported Q4 CY2025 results , but sales were flat year on year at $148.6 million. Its non-GAAP profit of $0.14 per share was in line with analysts’ consensus ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Life sciences company Azenta (NASDAQ:AZTA) announced in Q2 CY2026, with sales up 12% year on year to $161.2 million. Its non-GAAP profit of $0.16 per share was 60% above analysts’ consensus estimates.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Greetings, and welcome to the Azenta Second Quarter 2024 Financial Results. [Operator Instructions] As a reminder, this conference is being recorded, Wednesday, March 8 [May 8], 2024. I will now turn ...

Azenta’s Q4 non-GAAP EPS of $0.21 exceeded expectations by 10.53%. Revenue growth of 6% year-over-year to $159 million. Stock price increased by 13.43% in pre-market trading. Strong performance in the ...

Throughout the last three months, 5 analysts have evaluated Azenta (NASDAQ:AZTA), offering a diverse set of opinions from bullish to bearish. The following table provides a quick overview of their ...